Framing a Structure & Solutions
Envision Biotech Strategies supports management in the development of the company’s values and also helps transform them into tangible and actionable solutions.
We assess and determine the framework to establish the needed capabilities, infrastructure, and sustainable business practices to achieve your long-term vision and growth.
What We Do
Using a proven method together, we can answer a series of questions that help you define and prioritize your business growth. Once these questions are answered, we work with you to develop a roadmap on the capabilities and competencies that need to be added, outsourced and ignored, and how to prioritize.
Together we prioritize the needed capabilities and competencies while deprioritizing others, like what is required immediately, short-term, and long-term. We are always looking at what the company can afford, assess the company’s cash position, burn rate, and expected inflow of cash.
Envision Biotech Strategies
The company’s values guide our strategy, and that is how you’re going to achieve your envisioned future. It’s the roadmap you use to achieve your vision and reach your goals. The strategy will likely change due to many possibilities.
- Business conditions
- Medical reimbursement
- Regulatory requirements
- Technology breakthroughs
Our company’s values do not change.
Leadership must ask what the business stands for and define the culture of the business. Integrity, innovation, accuracy, loyalty, accountability, and teamwork are often used. The company’s values provide a clear understanding of what those values are and how they can contribute to them as they go about their daily work. Values keep the business on track through the many challenges it will face in the future.
Our vision is to develop clarity and purpose around the loftiest goals you have. It’s about what you want in the business, to create and achieve that in a broader sense over time, while providing the necessary level of excitement and motivation. It defines your long-term aspirations.
It explains why you’re doing what you’re doing and the ultimate good you want to achieve through your success. This vision might not be easy to realize and may require constant course changes, hard work, and many accumulated achievements over time.
Startups and many growing businesses have yet to clearly articulate their strategic path that begins with three well-known business concepts.
As needed, we leverage our network of associates to assess and develop your technology.
- Intellectual property strategy as well as freedom to operate position.
- Regulatory strategy and pathway.
- FDA medical device classification.
- The U.S. and global reimbursement strategy.
- Landscape, market, and competitive analysis.
- Target product profile and product development.
- Product positioning and messaging.
- Promotional strategy, medical writing, and promotional tactic resources.
- Key opinion leader management and social strategies.
- Patient resources, messaging, and strategy.
- Development of go-to-market strategy.
- Establishment and building of direct sales.
- Marketing and clinical education capabilities.
- Infrastructure and sustainable business practices.
We support you in all steps related to assessing, planning, and executing the commercialization of new technologies, products, and assets.
In today’s economic climate, most small companies do not have the financial resources, capabilities, or global reach to ‘go-it-alone.’ Investors, strategic partnerships, alliances, and relationships are often needed. We have vast experience in these areas.
The development of strategic partnerships and the expansion of global sales with an in-country distributor network is a typical new technology expansion strategy. Outside the U.S., the regulatory and product registration process is quite often much easier and may allow for a shorter timeline for generating revenue.
The Principle Consultant has established and successfully managed numerous partnerships with in-country distribution companies in Europe, Latin America, and throughout the Asia-Pacific area, including Japan, South Korea, China, Singapore, and Australia.